Stock AORT ARTIVION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Artivion, Inc.

Equities

AORT

US2289031005

Market Closed - Nyse
Other stock markets
 21:00:02 21/06/2024 BST 		5-day change 1st Jan Change
23.33 USD +1.00% Intraday chart for Artivion, Inc. +0.91% +30.48%
05-07 Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating MT
05-07 Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Artivion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Artivion, Inc. Revises Earnings Guidance for the Year 2024
Artivion Files Mixed Shelf
Artivion Insider Sold Shares Worth $1,358,818, According to a Recent SEC Filing
Artivion, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Artivion, Inc. Provides Earnings Guidance for the Year 2024
Artivion Enters $350 Million Credit Facilities
Artivion Insider Sold Shares Worth $273,543, According to a Recent SEC Filing
Artivion Completes Enrollment in Clinical Trial of Aortic Arch Remodeling Device
Artivion, Inc. Announces Completion of Enrollment in PERSEVERE Trial
Artivion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Artivion, Inc. Revises Earnings Guidance for the Year 2023
Artivion, Inc. Announces Data from On-X Aortic Heart Valve Low INR Post-Market Study Presented in A Late-Breaking Science Session At the 37European Association for Cardio-Thoracic Surgery Annual Meeting
Artivion, Inc. Revises Earnings Guidance for the Full Year 2023
Artivion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Insider Sell: Artivion
Sector Update: Health Care Stocks Dropping Late Afternoon
Sector Update: Health Care Stocks Declining Tuesday Afternoon
Artivion Receives FDA Premarket Application Approval for PerClot Bleeding Control System
Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AORT Stock
  4. News Artivion, Inc.
  5. Other languages